Defibrillators Market

Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospitals, Prehospital, Public Access, Home care) - Global Forecast to 2022

Report Code: MD 3124 Oct, 2019, by marketsandmarkets.com
Updated date -

[169 Pages Report] The global defibrillators market is projected to reach USD 10,883.3 million by 2022 from USD 9,323.5 million in 2017, at a CAGR of 3.1% during the forecast period. Factors such as technological advancements in defibrillators, increasing burden of target diseases, growing focus on providing public-access defibrillators, and rising number of training & awareness programs on defibrillators are driving the growth of this market.

Selected Market Dynamics in Defibrillators Market

Training & awareness programs on defibrillators

External defibrillation and cardiopulmonary resuscitation (CPR) are emergency medical procedures used to help people survive conditions such as sudden cardiac arrest (SCA). These can be performed by laypersons or emergency response professionals outside of hospitals.

In almost 80% of cases, cardiac arrests occur at home and are witnessed by a family member (Source: American Heart Association). Defibrillation within the first three minutes of SCA is effective and its effectiveness reduces by 10% for every minute that passes before defibrillation. Additionally, response times for most ambulances or emergency personnel can take longer than expected. It is evident that effective AED shock should be delivered to a victim within three to five minutes after the person collapses. Thus, the response time and efficiency of CPR and defibrillation play an important role in the success of cardiac resuscitation.

Various government and private bodies have engaged in training and awareness programs on defibrillation. Awareness and training related to the use and advantages of AEDs help reduce deaths from cardiac diseases.

Issues related to the use of implantable and automated external defibrillators

AEDs installed in public places are sometimes prone to failure due to problems pertaining to the battery, software, and hardware. Failure to perform defibrillation can result in delayed treatment or even death. Between January 2005 and September 2014, 72,000 medical device reports related to AED failure were received by the FDA. In the same period, manufacturers of AEDs conducted 111 product recalls, affecting over 2 million AED units. These problems were related to design and manufacturing issues.

Other major issues related to AEDs include faults in defibrillation pads, wiring, & circuit boards, and damaged cables & connectors. In some cases, the batteries of AEDs are removed when they are discharged; however, these batteries are not replaced on time. Although a number of initiatives are taken by public and private organizations as well as key market players to provide emergency services, these devices require proper maintenance and periodic servicing.

The report analyzes the global market by product, end user, and region.

On the basis of products, the market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and Cardiac Resynchronization Therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs). The ICDs segment is expected to account for the largest share of the global market in 2017. Factors such as the development of technologically advanced devices with extended longevity, rapid growth in the number of implant procedures, and increasing adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) and S-ICD systems across the globe are contributing to the large share of this segment.

Based on end user, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; pre-hospital care settings; public access markets; alternate care facilities; and home care settings. The public access markets segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment is attributed to the development of advanced AEDs, rising cases of sudden cardiac arrest at out-of-hospital settings, and increasing number of public access defibrillation programs across the globe.

This report covers the market data across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the global market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the rising incidence of target diseases in the region, technological advancements in defibrillators, and increasing number of public defibrillation programs in the region. Factors such as the rapidly growing aging population, increasing cases of cardiovascular diseases, improving research infrastructure, and growing focus of key market players to expand their presence in this region are driving the growth of the Asia Pacific market.

Defibrillators Market,by Region,2022(USD billion)

Issues related to the use of implantable and automated external defibrillators are expected to restrain the growth of the Defibrillators Market in the forecast period.

As of 2016, Medtronic (Ireland) dominates the global ICDs market through its broad product portfolio, strong geographical presence, and wide customer base in emerging economies. To maintain its leadership position in the market, the company has been focusing on technological advancements in implantable defibrillators. Other prominent players in the global ICD market included St. Jude Medical (US), Boston Scientific (US), BIOTRONIK (Germany), and LivaNova (UK).

ZOLL Medical (US) held the leadership position in the global external market. The company adopted new product launches, agreements, and partnerships as its core business strategies to enhance its share in the global external market. Other prominent players in the global external market included Philips (Netherlands), Physio-Control (US), Cardiac Science (US), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

 

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Definition
    1.3 Market Scope
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Primary Sources
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 31)
    4.1 Defibrillators: Market Overview
    4.2 Regional Analysis: Market, By Product
    4.3 Market, By End User
    4.4 Geographical Snapshot of the Market

5 Market Overview (Page No. - 34)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Technological Advancements in Defibrillators
                    5.2.1.2 Rising Prevalence of Target Diseases
                    5.2.1.3 Growing Focus on Providing Public-Access Defibrillators
                    5.2.1.4 Training & Awareness Programs on Defibrillators
           5.2.2 Restraints
                    5.2.2.1 Issues Related to the Use of Implantable and Automated External Defibrillators
           5.2.3 Opportunities
                    5.2.3.1 Emerging Markets Offer Significant Growth Opportunities
                    5.2.3.2 Development of S-ICDS and Mri-Compatible ICDS & CRT-DS
           5.2.4 Challenges
                    5.2.4.1 Frequent Product Recalls
                    5.2.4.2 Lack of Awareness About Sudden Cardiac Arrest in Developing Nations
    5.3 Industry Trends
           5.3.1 Increasing Pricing Pressure on Market Players
           5.3.2 Growing Number of Mergers and Acquisitions Among Market Players
           5.3.3 Rising Demand for Automated External Defibrillators in Prehospital Settings
    5.4 Regulatory Scenario
           5.4.1 External Defibrillators
           5.4.2 Implantable Defibrillators

6 Global Defibrillators Market, By Product (Page No. - 46)
    6.1 Introduction
    6.2 Implantable Cardioverter Defibrillators
           6.2.1 Transvenous Implantable Cardioverter Defibrillators
                    6.2.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators
                    6.2.1.2 Dual-Chamber ICDS
                    6.2.1.3 Single-Chamber ICDS
           6.2.2 Subcutaneous Implantable Cardioverter Defibrillators
    6.3 External Defibrillators
           6.3.1 Automated External Defibrillators
                    6.3.1.1 Semi-Automated External Defibrillators
                    6.3.1.2 Fully Automated External Defibrillators
           6.3.2 Manual External Defibrillators
           6.3.3 Wearable Cardioverter Defibrillators

7 Defibrillators Market, By End User (Page No. - 66)
    7.1 Introduction
    7.2 Hospitals, Clinics, and Cardiac Centers
    7.3 Pre-Hospital Care Settings
    7.4 Public Access Markets
    7.5 Home Care Settings
    7.6 Alternate Care Facilities

8 Defibrillators Market, By Region (Page No. - 74)
    8.1 Introduction
    8.2 North America
           8.2.1 US
           8.2.2 Canada
    8.3 Europe
           8.3.1 Germany
           8.3.2 UK
           8.3.3 France
           8.3.4 Rest of Europe
    8.4 Asia Pacific
           8.4.1 Japan
           8.4.2 China
           8.4.3 India
           8.4.4 Rest of Asia Pacific (RoAPAC)
    8.5 Rest of the World
           8.5.1 Latin America
           8.5.2 the Middle East
           8.5.3 Africa

9 Competitive Landscape (Page No. - 115)
    9.1 Introduction
    9.2 Market Share Analysis, 2016
           9.2.1 Implantable Cardioverter Market:  Key Players
           9.2.2 External Market: Key Players
    9.3 Competitive Scenario
           9.3.1 Key Product Launches and Approvals (2015-2017)
           9.3.2 Key Agreements, Partnerships, Contracts, and Collaborations (2015-2017)
           9.3.3 Key Expansions (2015-2017)
           9.3.4 Key Acquisitions, Joint Ventures, and Mergers (2015-2017)

10 Company Profiles (Page No. - 120)
(Business Overview, Products Offered, Recent Developments, MnM View)* 
     10.1 Medtronic
     10.2 St. Jude Medical
     10.3 Boston Scientific
     10.4 Philips
     10.5 Zoll Medical
     10.6 Biotronik
     10.7 Physio-Control
     10.8 Cardiac Science
     10.9 Livanova
     10.1 Nihon Kohden
     10.11 Schiller
     10.12 Mindray Medical
     10.13 Mediana
     10.14 Metrax
     10.15 Metsis Medikal
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies. 

11 Appendix (Page No. - 159)
     11.1 Discussion Guide
     11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     11.3 Introducing RT: Real-Time Market Intelligence
     11.4 Available Customizations
     11.5 Related Reports
     11.6 Author Details


List of Tables (95 Tables)

Table 1 Recent Product Innovations in the Defibrillators Market
Table 2 Market, By Region, 2015–2022 (USD Million)
Table 3 Market, By Product, 2015–2022 (USD Million)
Table 4 Implantable Cardioverter Market, By Region, 2015–2022 (USD Million)
Table 5 Global Implantable Cardioverter Defibrillator Market, By Region, 2015–2022 (No of Units)
Table 6 North American Implantable Cardioverter Defibrillator Market, By Country (Units)
Table 7 European Implantable Cardioverter Defibrillator Market, By Country (Units)
Table 8 Asia-Pacific Implantable Cardioverter Defibrillator Market, By Country (Units)
Table 9 RoW Implantable Cardioverter Defibrillator Market, By Country (Units)
Table 10 Implantable Cardioverter Market, By Type, 2015–2022 (USD Million)
Table 11 Transvenous Implantable Cardioverter Defibrillators Market, By Region, 2015–2022 (USD Million)
Table 12 Transvenous Implantable Cardioverter Market, By Type, 2015–2022 (USD Million)
Table 13 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators Market, By Region, 2015–2022 (USD Million)
Table 14 Dual-Chamber Implantable Cardioverter Market, By Region, 2015–2022 (USD Million)
Table 15 Single-Chamber Implantable Cardioverter Market, By Region, 2015–2022 (USD Million)
Table 16 Subcutaneous Implantable Cardioverter Market, By Region, 2015–2022 (USD Million)
Table 17 External Defibrillators Market, By Region, 2015–2022 (USD Million)
Table 18 Global External Market, By Region, 2015–2022 (No of Units)
Table 19 North American External Market, By Country (Units)
Table 20 European Implantable Cardioverter Defibrillator Market, By Country (Units)
Table 21 Asia-Pacific Implantable Cardioverter Defibrillator Market, By Country (Units)
Table 22 RoW Implantable Cardioverter Defibrillator Market, By Country (Units)
Table 23 External Market, By Type, 2015–2022 (USD Million)
Table 24 Automated External Defibrillators Market, By Region, 2015–2022 (USD Million)
Table 25 Automated External Market, By Type, 2015–2022 (USD Million)
Table 26 Semi-Automated External Defibrillators Market, By Region, 2015–2022 (USD Million)
Table 27 Fully Automated External Market, By Region, 2015–2022 (USD Million)
Table 28 Manual External Market, By Region, 2015–2022 (USD Million)
Table 29 Wearable Cardioverter Market, By Region, 2015–2022 (USD Million)
Table 30 Market, By End User, 2015–2022 (USD Million)
Table 31 Market for Hospitals, Clinics, and Cardiac Centers, By Region, 2015–2022 (USD Million)
Table 32 Market for Pre-Hospital Care Settings, By Region, 2015–2022 (USD Million)
Table 33 Market for Public Access Markets, By Region, 2015–2022 (USD Million)
Table 34 Market for Home Care Settings, By Region, 2015–2022 (USD Million)
Table 35 Market for Alternate Care Markets, By Region, 2015–2022 (USD Million)
Table 36 Market, By Region, 2015–2022 (USD Million)
Table 37 Market, By Region (Units)
Table 38 North American Market, By Country (Units)
Table 39 European Market, By Country (Units)
Table 40 Asia-Pacific Defibrillators Market, By Country (Units)
Table 41 RoW Market, By Country (Units)
Table 42 North America: Defibrillators Market, By Country, 2015–2022 (USD Million)
Table 43 North America: Market, By Product, 2015–2022 (USD Million)
Table 44 North America: Implantable Cardioverter Market, By Type, 2015–2022 (USD Million)
Table 45 North America: Transvenous Implantable Cardioverter Defibrillators Market, By Type, 2015–2022 (USD Million)
Table 46 North America: External Market, By Type, 2015–2022 (USD Million)
Table 47 North America: Automated External Market, By Type, 2015–2022 (USD Million)
Table 48 North America: Market, By End User, 2015–2022 (USD Million)
Table 49 US: Market, By Product, 2015–2022 (USD Million)
Table 50 US: Market, By End User, 2015–2022 (USD Million)
Table 51 Canada: Market, By Product, 2015–2022 (USD Million)
Table 52 Canada: Market, By End User, 2015–2022 (USD Million)
Table 53 Europe: Market, By Country, 2015–2022 (USD Million)
Table 54 Europe: Market, By Product, 2015–2022 (USD Million)
Table 55 Europe: Implantable Cardioverter Market, By Type, 2015–2022 (USD Million)
Table 56 Europe: Transvenous Implantable Cardioverter Defibrillators Market, By Type, 2015–2022 (USD Million)
Table 57 Europe: External Market, By Type, 2015–2022 (USD Million)
Table 58 Europe: Automated External Defibrillators Market, By Type, 2015–2022 (USD Million)
Table 59 Europe: Market, By End User, 2015–2022 (USD Million)
Table 60 Germany: Market, By Product, 2015–2022 (USD Million)
Table 61 Germany: Market, By End User, 2015–2022 (USD Million)
Table 62 UK: Market, By Product, 2015–2022 (USD Million)
Table 63 UK: Market, By End User, 2015–2022 (USD Million)
Table 64 France: Market, By Product, 2015–2022 (USD Million)
Table 65 France: Market, By End User, 2015–2022 (USD Million)
Table 66 RoE: Market, By Product, 2015–2022 (USD Million)
Table 67 RoE: Market, By End User, 2015–2022 (USD Million)
Table 68 Asia Pacific: Defibrillators Market, By Country, 2015–2022 (USD Million)
Table 69 Asia Pacific: Market, By Product, 2015–2022 (USD Million)
Table 70 Asia Pacific: Implantable Cardioverter Defibrillators Market, By Type, 2015–2022 (USD Million)
Table 71 Asia Pacific: Transvenous Implantable Cardioverter Defibrillators Market, By Type, 2015–2022 (USD Million)
Table 72 Asia Pacific: External Market, By Type, 2015–2022 (USD Million)
Table 73 Asia Pacific: Automated External Market, By Type, 2015–2022 (USD Million)
Table 74 Asia Pacific: Market, By End User, 2015–2022 (USD Million)
Table 75 Japan: Market, By Product, 2015–2022 (USD Million)
Table 76 Japan: Market, By End User, 2015–2022 (USD Million)
Table 77 China: Market, By Product, 2015–2022 (USD Million)
Table 78 China: Market, By End User, 2015–2022 (USD Million)
Table 79 India: Market, By Product, 2015–2022 (USD Million)
Table 80 India: Market, By End User, 2015–2022 (USD Million)
Table 81 Rest of Asia Pacific: Market, By Product, 2015–2022 (USD Million)
Table 82 Rest of Asia Pacific: Market, By End User, 2015–2022 (USD Million)
Table 83 RoW: Market, By Region, 2015–2022 (USD Million)
Table 84 RoW: Market, By Product, 2015–2022 (USD Million)
Table 85 RoW: Implantable Cardioverter Market, By Type, 2015–2022 (USD Million)
Table 86 RoW: Transvenous Implantable Cardioverter Defibrillators Market, By Type, 2015–2022 (USD Million)
Table 87 RoW: External Market, By Type, 2015–2022 (USD Million)
Table 88 RoW: Automated External Defibrillators Market, By Type, 2015–2022 (USD Million)
Table 89 RoW: Market, By End User, 2015–2022 (USD Million)
Table 90 Latin America: Market, By Product, 2015–2022 (USD Million)
Table 91 Latin America: Market, By End User, 2015–2022 (USD Million)
Table 92 Middle East: Market, By Product, 2015–2022 (USD Million)
Table 93 Middle East: Market, By End User, 2015–2022 (USD Million)
Table 94 Africa: Market, By Product, 2015–2022 (USD Million)
Table 95 Africa: Market, By End User, 2015–2022 (USD Million)


List of Figures (28 Figures)

Figure 1 Markets Covered
Figure 2 Research Design
Figure 3 Data Triangulation
Figure 4 Defibrillators Product Market Snapshot (2017 vs. 2022)
Figure 5 Global Market, By End User (2017 vs. 2022)
Figure 6 Market, By Region, 2017
Figure 7 Technological Advancements in Defibrillators and Growing Focus on Providing Public-Access Defibrillators are Major Factors Driving Market Growth
Figure 8 CRT-DS Segment to Account for the Largest Share of the Defibrillators Market in 2017
Figure 9 Hospitals, Clinics, and Cardiac Centers Will Continue to Dominate the Market By 2022
Figure 10 Asia Pacific to Register the Highest Cagr During the Forecast Period
Figure 11 Market: Drivers, Restraints, Opportunities, & Challenges
Figure 12 Geriatric Population, By Region, 2015 - 2050 (Million)
Figure 13 Recent Product Recall By Fda (US) of Major Defibrillator Brands (2016 -2018)
Figure 14 CRT-DS Will Continue to Dominate the Market Till 2022
Figure 15 North America: Market Snapshot
Figure 16 Europe: Market Snapshot, 2017-2022
Figure 17 Asia Pacific: Market Snapshot, 2017–2022
Figure 18 Row: Market Snapshot, 2017–2022
Figure 19 Key Developments By Leading Market Players in the Market, 2014–2017
Figure 20 ICDS and External Market Share, By Key Player, 2016
Figure 21 Medtronic: Company Snapshot
Figure 22 St. Jude Medical: Company Snapshot
Figure 23 Boston Scientific: Company Snapshot
Figure 24 Koninklijke Philips N.V.: Company Snapshot
Figure 25 Asahi Kasei: Company Snapshot
Figure 26 Stryker: Company Snapshot
Figure 27 Livanova: Company Snapshot
Figure 28 Nihon Kohden: Company Snapshot

This study involved four major activities in estimating the current size of the global defibrillators market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation processes were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was conducted to obtain key information about market classification and segmentation, geographical scenario, key developments undertaken by major market players, and the identification of key industry trends. The secondary sources used for this study include annual reports, press releases, and investor presentations of companies; white papers; certified publications; and articles from recognized websites, databases, and directories.

Primary Research

Extensive primary research was conducted after acquiring a preliminary understanding of the global defibrillators market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (hospitals, clinics, and cardiac centers; pre-hospital care settings; public access markets; and alternate care facilities among others) and supply-side respondents (such as C & D-level executives & product managers of key manufacturers, distributors, and channel partners) across North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 30% and 70% of primary interviews were conducted with both the demand- and supply-side respondents, respectively. The primary data was collected through questionnaires, e-mails, online surveys, and telephonic interviews. A breakdown of primary respondents is provided below:

Defibrillators Market:Breakup of Primary Interviews

Market Estimation Methodology

  • A detailed market estimation approach was followed to estimate and validate the size of the global market and other dependent submarkets.
  • The key players in the global market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology includes the study of the annual and quarterly financial reports of top market players as well as interviews with industry experts to gather key insights on various market segments and subsegments.
  • All segmental shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • Major macroindicators in play have been accounted for, viewed in detail, verified through primary research, and analyzed to understand their impact on market growth and various segments and subsegments.
  • The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Data Triangulation:

After deriving the overall market value from the market size estimation process explained above, the total market value data was split into several segments and subsegments. Data triangulation and market breakdown were undertaken to complete the overall market engineering process and arrive at the exact statistics for all segments, wherever applicable. The data was triangulated by studying various qualitative & quantitative variables as well as by analyzing regional trends for both the demand and supply-side macroindicators.

Report Objectives:

  • To define, describe, segment and forecast the market on the basis of product, end user, and region
  • To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges) along with the current trends
  • To strategically analyze micromarkets1 with respect to their individual growth trends, future prospects, and contributions to the total market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue and volume of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
  • To profile the key players and comprehensively analyze their market shares and core competencies2
  • To track and analyze competitive developments such as product launches & approvals; agreements, partnerships, contracts, and collaborations; mergers, joint ventures, and acquisitions; and expansions in the market.

Scope of the report

Report Metric

Details

Market Size Available for Years

2015–2022

Base Year Considered

2016

Forecast Period

2017–2022

Currency Used

Value (USD Million)

Segments Covered

Product Type, End User, and Region

Geographies Covered

North America, Europe, Asia Pacific, Rest of the World

Companies Covered

15 major players, including Medtronic (Ireland), St. Jude Medical (US), Boston Scientific (US), Philips (the Netherlands), ZOLL Medical (US), BIOTRONIK (Germany), Physio-Control (US), Cardiac Science (US), LivaNova (UK), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey) are some major players in the global defibrillators market.


In this report, the global market has been segmented based on product type, end user, and region.

Global Defibrillators Market, by Product Type

  • Implantable Cardioverter Defibrillators (ICDS)
    • Transvenous Implantable Cardioverter Defibrillators (TICDS)
      • Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
      • Dual-chamber ICDS
      • Single-chamber ICDS
  • Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
  • External Defibrillators
    • Automated External Defibrillators (AEDS)
      • Semi-automated External Defibrillators
      • Fully Automated External Defibrillators
    • Manual External Defibrillators
    • Wearable Cardioverter
    • Defibrillators (WCDS)

Global Defibrillators Market, by End User

  • Hospitals, Clinics, and Cardiac Centers
  • Pre-hospital Care Settings
  • Public Access Markets
  • Home Care Settings
  • Alternate Care Facilities 

Global Defibrillators Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the market

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
MD 3124
Published ON
Oct, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Defibrillators Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home